Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/12/17
End: 06/15/20
Due: 06/15/21
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 04/27/20
Due: 04/27/21
Phase: N/A
Priority: Normal
Start: 12/19/23
End: 03/05/25
Due: 03/05/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE | NCT03098823 | Ampel BioSolutions, LLC | user2@example.com | None | 2017-09-12 | 2020-06-15 | 2021-06-15 | - | - | 2025-07-14 |
| Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect | NCT02598596 | Ampel BioSolutions, LLC | user2@example.com | None | 2015-12-31 | 2020-04-27 | 2021-04-27 | - | - | 2025-07-14 |
| Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) | NCT05845593 | Ampel BioSolutions, LLC | user2@example.com | None | 2023-12-19 | 2025-03-05 | 2026-03-05 | - | - | 2025-07-14 |